These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8268919)

  • 1. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome.
    Hornstra IK; Nelson DL; Warren ST; Yang TP
    Hum Mol Genet; 1993 Oct; 2(10):1659-65. PubMed ID: 8268919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.
    Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD
    Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1.
    Stöger R; Kajimura TM; Brown WT; Laird CD
    Hum Mol Genet; 1997 Oct; 6(11):1791-801. PubMed ID: 9302255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C; Nielsen AL
    Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.
    Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K
    Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5' region on the active and inactive X chromosomes: correlation with binding sites for transcription factors.
    Hornstra IK; Yang TP
    Mol Cell Biol; 1994 Feb; 14(2):1419-30. PubMed ID: 8289817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.
    Burman RW; Yates PA; Green LD; Jacky PB; Turker MS; Popovich BW
    Am J Hum Genet; 1999 Nov; 65(5):1375-86. PubMed ID: 10521303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
    Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
    Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the FMR1 gene mutation to human intellectual dysfunction.
    Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB
    Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable DNA methylation boundaries and expanded trinucleotide repeats: role of DNA insertions.
    Naumann A; Kraus C; Hoogeveen A; Ramirez CM; Doerfler W
    J Mol Biol; 2014 Jul; 426(14):2554-66. PubMed ID: 24816393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene.
    Milà M; Castellví-Bel S; Sánchez A; Lázaro C; Villa M; Estivill X
    J Med Genet; 1996 Apr; 33(4):338-40. PubMed ID: 8730293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleosomal occupancy and CGG repeat expansion: a comparative analysis of triplet repeat region from mouse and human fragile X mental retardation gene 1.
    Datta S; Alam MP; Majumdar SS; Mehta AK; Maiti S; Wadhwa N; Brahmachari V
    Chromosome Res; 2011 May; 19(4):445-55. PubMed ID: 21499798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter.
    Ritchie RJ; Knight SJ; Hirst MC; Grewal PK; Bobrow M; Cross GS; Davies KE
    Hum Mol Genet; 1994 Dec; 3(12):2115-21. PubMed ID: 7881407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.
    Knight SJ; Flannery AV; Hirst MC; Campbell L; Christodoulou Z; Phelps SR; Pointon J; Middleton-Price HR; Barnicoat A; Pembrey ME
    Cell; 1993 Jul; 74(1):127-34. PubMed ID: 8334699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.